← Back to guidelines
Cardiology1 paper

Hyperosmolar coma due to type 2 diabetes mellitus

Last edited: 4/22/2026

Overview

Hyperosmolar coma in type 2 diabetes mellitus is characterized by severe hyperglycemia leading to extreme hyperosmolarity without significant ketoacidosis, often presenting with altered mental status and dehydration 1.

Diagnosis

  • Clinical Presentation: Altered mental status, polydipsia, polyuria, severe hyperglycemia (often >600 mg/dL), and elevated serum osmolality (typically >320 mOsm/kg) 1.
  • Laboratory Tests: Blood glucose, serum osmolality, electrolytes, renal function tests, and absence of significant ketonuria 1.
  • Imaging/Special Tests: Not typically required unless underlying causes like hepatic shunts are suspected 1.
  • Management

  • Fluid Resuscitation: Initial isotonic saline to correct dehydration, followed by hypotonic fluids (e.g., half-normal saline) to gradually reduce osmolality 1.
  • Insulin Therapy: Subcutaneous or intravenous insulin to lower blood glucose levels gradually, aiming for a reduction of 50-75 mg/dL per hour 1.
  • Electrolyte Management: Monitor and correct electrolyte imbalances, particularly potassium levels 1.
  • Address Underlying Causes: Investigate and manage precipitating factors such as infections, non-adherence, or other comorbidities 1.
  • Special Populations

  • Pediatrics: Not addressed in provided abstracts 1.
  • Elderly: Increased risk of complications; careful fluid and insulin management is crucial 1.
  • Comorbidities: Management should consider coexisting conditions like cardiovascular disease, renal impairment, or hepatic shunts (as seen in rare cases) 1.
  • Key Recommendations

  • Initiate fluid resuscitation with isotonic saline followed by hypotonic fluids to correct dehydration (Evidence: Moderate) 1.
  • Administer insulin to gradually lower blood glucose levels, avoiding rapid correction to prevent cerebral edema (Evidence: Moderate) 1.
  • Thoroughly investigate and manage underlying precipitating factors such as infections or non-adherence to diabetes management (Evidence: Expert opinion) 1.
  • References

    1 Matsumoto T, Okano R, Sakura N, Kawaguchi Y, Tanaka Y, Ueda K et al.. Hypergalactosaemia in a patient with portal-hepatic venous and hepatic arterio-venous shunts detected by neonatal screening. European journal of pediatrics 1993. link

    Original source

    1. [1]
      Hypergalactosaemia in a patient with portal-hepatic venous and hepatic arterio-venous shunts detected by neonatal screening.Matsumoto T, Okano R, Sakura N, Kawaguchi Y, Tanaka Y, Ueda K et al. European journal of pediatrics (1993)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG